Use of non-feminizing estrogens as retinoprotective agents for the treatment of glaucoma

Details for Australian Patent Application No. 2002326807 (hide)

Owner Alcon, Inc

Inventors Pang, Iok-Hou; Clark, Abbot F.

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2002326807

PCT Number PCT/US02/27969

PCT Pub. Number WO2003/020284

Priority 60/317,225 05.09.01 US

Filing date 3 September 2002

Wipo publication date 18 March 2003

Acceptance publication date 23 August 2007

International Classifications

A61K 31/565 (2006.01) - not substituted in position 17 beta by a carbon atom, e.g. oestrane, oestradiol

A61K 31/566 (2006.01) - having an oxo group in position 17, e.g. oestrone

A61K 31/567 (2006.01) - substituted in position 17 alpha, e.g. mestranol, norethandrolone

A61P 27/02 (2006.01) Drugs for disorders of the senses

A61P 27/06 (2006.01) Drugs for disorders of the senses

C07J 1/00 (2006.01) Normal steroids, i.e. cyclopenta[a]hydrophenanthrenes, containing carbon, hydrogen, halogen, or oxygen

Event Publications

23 January 2003 Complete Application Filed

  Priority application(s): 60/317,225 05.09.01 US

5 June 2003 Application Open to Public Inspection

  Published as AU-B-2002326807

23 August 2007 Application Accepted

  Published as AU-B-2002326807

20 December 2007 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002326808-MAMMALIAN GENES; RELATED REAGENTS

2002326806-Analgetic pyrroline derivatives